TICAGRELOR
Generic: TICAGRELOR
Ascend LaboratoriesManufacturer
ORALRoute
TICAGRELORActive Substance
2023-04-21Original Approval
TICAGRELOR is FDA application ANDA208567, sponsored by ALKEM LABS LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INTERACTION
875 reports
2
DYSPNOEA
770 reports
3
RHABDOMYOLYSIS
660 reports
4
ACUTE KIDNEY INJURY
617 reports
5
MYOCARDIAL INFARCTION
534 reports
6
CHEST PAIN
404 reports
7
DRUG INEFFECTIVE
404 reports
8
ACUTE MYOCARDIAL INFARCTION
393 reports
9
CHEST DISCOMFORT
346 reports
10
ANAEMIA
329 reports